The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVersarien Regulatory News (VRS)

Share Price Information for Versarien (VRS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.108
Bid: 0.103
Ask: 0.1095
Change: 0.00025 (0.24%)
Spread: 0.0065 (6.311%)
Open: 0.105
High: 0.108
Low: 0.105
Prev. Close: 0.106
VRS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Exercise of Options

7 Dec 2017 07:00

RNS Number : 6262Y
Versarien PLC
07 December 2017
 

7 December 2017

Versarien plc

("Versarien" or the "Company")

Exercise of Options

Director/PDMR Shareholding

Versarien plc (AIM: VRS), the advanced materials engineering group, announces it has issued 910,900 ordinary shares of 1 pence each in the Company ("Ordinary Shares") following the exercise by directors and an employee of the Company under the Company's share option schemes.

Named person

No. options exercised

Exercise price per share

Neill Ricketts

250,000

12.25p

Chris Leigh

528,720

15.50p

Employee (non-PDMR)

132,180

12.25p

Total

910,900

 

 

Application has been made for the new Ordinary Shares to be admitted to trading on AIM, which is expected to take place on 11 December 2017. The new Ordinary Shares will rank, pari passu, with the existing Ordinary Shares in issue.

The Company was also notified that Christopher Leigh, Chief Financial Officer has sold 528,720 Ordinary Shares at an average price of 73.81 pence per Ordinary Share.

Following the transactions outlined above:

Mr Ricketts' interest in the share capital of the Company has increased to a total of 15,625,000 Ordinary Shares representing 10.53 per cent. of the Company's issued share capital enlarged pursuant to the exercise of options. Mr Ricketts is further interested in 278,720 options exercisable at 12.25 pence per share together with 2,626,614 options exercisable at 15 pence per share and 1,050,761 options exercisable at 29 pence per share; and

Mr Leigh's interest in the share capital of the Company has remained at a total of 315,000 Ordinary Shares representing 0.21 per cent. of the Company's issued share capital enlarged pursuant to the exercise of options. Mr Leigh is further interested in 2,626,614 options exercisable at 15 pence per share and 1,050,761 options exercisable at 29 pence per share.

Total Voting Rights

Following the issue of the new Ordinary Shares, the Company will have 148,386,309 ordinary shares of 1 pence each in issue. No Ordinary Shares are held in treasury. The figure of 148,386,309 may be used by the Company's shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Enquiries:

Versarien 01242 269 122

Neill Ricketts, CEO

Chris Leigh, CFO

WH Ireland (Nominated Advisor) 0117 945 3470

Mike Coe / Ed Allsopp

IFC Advisory (Financial PR and IR) 0203 053 8671

Tim Metcalfe

Graham Herring

Heather Armstrong

 

The information below, set out in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Neill Ricketts

2

Reason for the notification

a)

Position/status

Chief Executive Officer

b)

Initial notification/ Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Versarien plc

b)

LEI

213800D6NZED7V8W2Z34

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 1p each

 

GB00B8YZTJ80

b)

Nature of the transaction

Exercise of options

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

12.25p

250,000

 

d)

Aggregated information

- Aggregated volume

- Price

 

250,000

£30,625

e)

Date of the transaction

5 December 2017

f)

Place of the transaction

London Stock Exchange, AIM

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Christopher Leigh

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

Initial notification/ Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Versarien plc

b)

LEI

213800D6NZED7V8W2Z34

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 1p each

 

GB00B8YZTJ80

b)

Nature of the transaction

Exercise and sale of options

c)

Price(s) and volume(s)

Exercise:

Price(s)

Volume(s)

15.50p

528,720

 

Sale:

Price(s)

Volume(s)

74.00p

73.64p

250,000

278,720

 

d)

Aggregated information

- Aggregated volume

- Price

 

- Aggregated volume

- Price

 Exercise:

528,720

£81,952

Sale:

528,720

£390,249

e)

Date of the transaction

5 December 2017

f)

Place of the transaction

London Stock Exchange, AIM

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHOKADPCBDDQBK
Date   Source Headline
28th Mar 20247:00 amRNSAudited Results for year ended 30 September 2023
28th Mar 20247:00 amRNSTotal Voting Rights
20th Mar 20248:33 amRNSPlacing to raise £615,000
14th Mar 20247:00 amRNSSouth American Graphinks Agreements
11th Mar 20247:00 amRNSSale of Korean Assets and Licencing of IP
16th Feb 20242:22 pmRNSNotification of final results
7th Feb 20247:00 amRNSReceipt of Legal Claims
31st Jan 20247:00 amRNSTotal Voting Rights
23rd Jan 20244:53 pmRNSHolding(s) in Company
23rd Jan 20241:24 pmRNSHolding(s) in Company
19th Jan 20247:00 amRNSPlacing to raise £400,000
10th Jan 202411:29 amRNSResult of General Meeting
20th Dec 20237:00 amRNSCompany Update and Notice of General Meeting
30th Nov 20237:00 amRNSTotal Voting Rights
8th Nov 20237:00 amRNSPlacing to raise £454,822
30th Oct 202311:52 amRNSResult of General Meeting
30th Oct 20237:00 amRNSGeneral Meeting Statement
12th Oct 20237:00 amRNSNotice of General Meeting
2nd Oct 20237:00 amRNSCorporate Update
13th Sep 20237:00 amRNSTurnaround Strategy - Gnanomat Grant Award
31st Jul 20237:00 amRNSTotal Voting Rights
18th Jul 20234:31 pmRNSDirectorate Changes
14th Jul 20237:00 amRNSPlacing to raise £650,000
4th Jul 202310:54 amRNSResult of General Meeting
4th Jul 20237:00 amRNSGeneral Meeting Statement
15th Jun 20237:00 amRNSNotice of General Meeting
9th Jun 20237:00 amRNSInterim Results
31st May 20237:00 amRNSTotal Voting Rights
17th May 20237:00 amRNSSuccessful Cementene precast concrete trials
3rd May 20239:30 amRNSPlacing and Update on Turnaround Strategy
31st Mar 20237:00 amRNSTotal Voting Rights
29th Mar 202311:22 amRNSResult of AGM
29th Mar 20237:00 amRNSAGM Statement
15th Mar 20237:00 amRNSPlacing to raise £318,000
14th Mar 20232:56 pmRNSFurther re Resignation of Chief Executive Officer
10th Mar 20237:00 amRNSResignation of Chief Executive Officer
6th Mar 20237:00 amRNSCostain Civil Engineering Project
1st Mar 202312:00 pmRNSUmbro Launch
28th Feb 20237:00 amRNSNotice of AGM and Posting of Annual Report
21st Feb 20237:00 amRNSResults for the 18 months ended 30 September 2022
9th Feb 20238:33 amRNSAIM Rule 17 Update
27th Jan 20237:00 amRNSGraphene-Wear OEKO-TEX Eco Passport certification
24th Jan 20231:56 pmRNSFinal Results Update
30th Dec 20227:00 amRNSTotal Voting Rights
6th Dec 20229:40 amRNSPlacing to raise £1.85 million
5th Dec 20224:40 pmRNSSecond Price Monitoring Extn
5th Dec 20224:35 pmRNSPrice Monitoring Extension
5th Dec 20227:00 amRNSG-SCALE Update & Innovate UK Loan Variation
2nd Dec 20224:35 pmRNSPrice Monitoring Extension
1st Dec 20224:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.